FDA
-
-
-
-
-
-
-
K2M Group Holdings, Inc. Reports Second Quarter 2018 Financial Results and Updates Fiscal Year 2018 Outlook
-
-
-
-
-
-
-
K2M Receives FDA Clearance for BACS® Patient-Specific Module
-
-
-
-
-
-
-
K2M Group Holdings, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results
-
-
-
-
-
-
-
K2M Receives FDA Clearance for Next-Generation YUKON™ OCT Spinal System
-
-
-
-
-
-
-
K2M Receives FDA Clearance & CE Mark for NILE® Proximal Fixation Spinal System
-
-
-
-
-
-
-
K2M Group Holdings, Inc. Announces Proposed Sale of Shares of Common Stock by Selling Stockholders
-
-
328,413 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

